Clariyon’s AI tool boosts sepsis care compliance in hospital study

Clariyon debuts this data as 1.7 million adults in the US are diagnosed with sepsis each year, and AI tools gain prevalence in healthcare. This data debuts as 1.7 million adults in the US are diagnosed with sepsis each year. Clariyon’s AI agent boosted physician sepsis care compliance by 13% in a clinical trial. Credit: ImageFlow / Shutterstock.com. Clariyon’s artificial intelligence (AI)-powered sepsis care agent has shown potential in improving a physician’s ability to provide quality care to patients in the hospital setting. In a clinical trial (NCT07581340), which was held across two academic emergency departments within the University of…

Source: Medical Device Network